Goldenwell Biotech, Inc.
GWLL
$3.00
$0.000.00%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 850.00% | 197.67% | -29.34% | -7.14% | -59.66% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | 0.06% | 0.06% | 0.06% | -0.06% | -0.17% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 22.85% | 25.40% | -3.57% | -1.71% | -4.01% |
|
|
|||||
| Total Current Assets | 22.85% | 25.40% | -3.57% | -1.71% | -4.01% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 22.85% | 25.40% | -3.57% | -1.71% | -4.01% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 3,183.33% | 5,266.67% | 58.33% | 0.00% | -14.29% |
| Total Other Current Liabilities | 3,183.33% | 5,266.67% | 58.33% | 0.00% | -14.29% |
| Total Current Liabilities | 3,183.33% | 5,266.67% | 58.33% | 0.00% | -14.29% |
|
|
|||||
| Total Current Liabilities | 3,183.33% | 5,266.67% | 58.33% | 0.00% | -14.29% |
| Long-Term Debt | 39.70% | 40.12% | 88.68% | 89.99% | 146.88% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 58.63% | 71.97% | 88.36% | 88.73% | 144.10% |
|
|
|||||
| Common Stock & APIC | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Retained Earnings | -5.68% | -6.92% | -10.75% | -10.71% | -10.33% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -393.75% | -2,384.21% | -251.96% | -155.99% | -118.20% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -393.75% | -2,384.21% | -251.96% | -155.99% | -118.20% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -393.75% | -2,384.21% | -251.96% | -155.99% | -118.20% |
|
|
|||||